Has Baominh Vinh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $44,100 in general payments to Baominh Vinh, MD across 903 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Baominh Vinh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Baominh Vinh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Baominh Vinh, MD

Pain Medicine · Houston, TXNPI 1578707303

Payments from drug & device makers

$44,100in general payments, 2019–2025

Across 903 payments — averaging $48.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stimwave Technologies Incorporated$6K
Medtronic$4K
Saluda Medical Americas, Inc.$4K
Boston Scientific$3K
Nevro Corp.$2K
Vertiflex, Inc.$2K
plus $22K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stimwave Technologies Incorporated	20	$6,428
Medtronic(2 entities)	47	$3,744
Saluda Medical Americas, Inc.	39	$3,708
Boston Scientific	36	$3,432
Nevro Corp.	31	$2,299
Vertiflex, Inc.	22	$2,238
Relievant Medsystems, Inc.	30	$2,088
Abbott	32	$1,808
Biohaven Pharmaceuticals, Inc.	18	$1,783
AbbVie(2 entities)	62	$1,329
Acelrx Pharmaceuticals, Inc.	5	$1,165
Spinal Simplicity, LLC	13	$1,143
Nalu Medical, Inc.	19	$864
Collegium Pharmaceutical, Inc.	60	$818
Vertos Medical, Inc.	10	$795
Merz Pharmaceuticals, LLC	39	$775
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	53	$762
MDD US Operations, LLC	27	$712
Tersera Therapeutics LLC	26	$699
Painteq LLC	15	$651
MML US, Inc.	15	$649
Pfizer	20	$463
Daiichi Sankyo Inc.	26	$419
Genesys Orthopedics Systems, L.L.C.	1	$352
Pacira Therapeutics, Inc.	22	$350
Biotronik NRO, Inc.	6	$324
Amgen(2 entities)	14	$302
Biodelivery Sciences International, Inc.	15	$293
Globus Medical	4	$272
Merz North America, Inc.	9	$254
Zyla Life Sciences, Inc.	25	$223
Si-bone, Inc.	4	$201
Biohaven Pharmaceutical Holding Company Ltd.	11	$186
Scilex Pharmaceuticals Inc.	11	$183
Azurity Pharmaceuticals, Inc.	9	$180
Novartis	9	$162
GRT US Holding, Inc.	3	$157
Teva Pharmaceuticals USA, Inc.	7	$129
Vertex	4	$127
IBSA Pharma Inc.	8	$126
Jazz Pharmaceuticals Inc.	1	$120
Arbor Pharmaceuticals, Inc.	7	$107
Johnson & Johnson	8	$103
Axsome Therapeutics, Inc.	3	$97
VGI Medical, LLC	1	$87
Supernus Pharmaceuticals, Inc.	5	$76
Sentynl Therapeutics, Inc.	5	$71
Lilly USA, LLC	4	$70
Almatica Pharma LLC	4	$65
Piramal Critical Care	4	$62
Redhill Biopharma Inc.	3	$47
Baudax Bio Inc.	2	$43
Eisai Inc.	2	$41
Zimmer Biomet	2	$40
Masimo Corporation	2	$39
Innovation Technologies Inc	2	$39
Upsher-smith Laboratories LLC	2	$38
Fujifilm Sonosite, Inc.	1	$35
Flowonix Medical Incorporated	2	$34
Bausch Health US, LLC	1	$33

How this compares

$44,100 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$351,778

Medicare patients

220

Services billed

12,681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Houston

Mitchell EngleHouston$1.5M
Daniel PakHouston$460K
David LeimanHouston$281K
Grant ChenHouston$175K
Gunjan PatelHouston$166K
Jaideep MehtaHouston$161K
Mayur KanjiaHouston$46K
Matthew ChungHouston$26K
Aaron CalodneyTyler$3M
Melissa MurphyGrapevine$711K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →